Reading UHT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track UHT free→Reading UHT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track UHT free→NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-06-16
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is neutral, and earnings quality is robust, cash backs up reported profits. Management's recent track record has been neutral, and the company's capital stance is capital unfriendly. Risk is moderate, and the sector backdrop is a headwind, although UHT trades above typical compared to sector peers. Peer multiples imply a price roughly in line with where it trades (about fair); the read is fair. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $39.98. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $40 the market pays 31× p/e — above the 14× p/e peer median but in line with its own 31× history. That premium reflects a durable franchise our peer-anchored $40 fair value understates; treat the 'expensive vs peers' read with low confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 1% near-term growth, in line with our forecast of about 3%. This describes what's priced in, not a forecast of the move.
Only a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Real Estate names rated neutral grew net income 53% of the time over the next year (vs 57% for the rest of the cohort, n=1968).
Over the trailing year it converted 2.77x of net income into operating cash flow. Historically, Real Estate names rated robust grew net income 59% of the time over the next year (vs 50% for the rest of the cohort, n=1399).
Most sensitive to real (inflation-adjusted) rates and long-term interest rates.
Not enough signal to read sensitivity to the US dollar, the broad stock market, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
0 upgrades, 0 downgrades / 30d. 0% of analysts rate Buy.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$75.
How much price usually moves either way.
On a bad day, this stock has moved -$228.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,437.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: FFO growth shows good operations and helps keep dividends. Drops may cause worry.
Confirms:FFO per share increases compared to Q1 2026.
Disproves:FFO per share decreases compared to Q1 2026.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for UHT yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 2026 Long-Term Incentive, Annual Restricted Stock Awards The chief element of compensation for our executive officers has historically been the annual granting of long-term incentive awards. As reflected on the table below, on June 10, 2026, the Compensation Committee of the Board of Trustees recommended, and the Board of Trustees granted, restrict…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Health Care REITs.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
UHT Universal Health Realty Income Trust | Above typical Show detailsSector percentile: 96 of 100 | fair | moderate |
WELL Welltower | Typical Show detailsSector percentile: 58 of 100 | expensive | low |
VTR Ventas | Typical Show detailsSector percentile: 39 of 100 | expensive | moderate |
OHI Omega Healthcare Investors | Typical Show detailsSector percentile: 68 of 100 | expensive | moderate |
DOC Healthpeak Properties | Above typical Show detailsSector percentile: 76 of 100 | fair | moderate |
3 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Real Estate names rated neutral grew net income 57% of the time over the next year (vs 55% for the rest of the cohort, n=5004).
Not investment advice. As of 2026-06-16.
via XLRE
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Complete construction of the Miller Medical Plaza by Q4 2026.
Amend credit agreement to increase borrowing capacity to $475 million.
Continue regular dividend payments to shareholders.
Why it matters: Better sector performance could mean a good environment for UHT's growth.
Confirms:Sector performance shows a positive change, moving above 0% over a 60-day period.
Disproves:Sector performance keeps falling, staying below -5% for 60 days.
Why it matters: Stable lease revenue is key for income. Drops may show tenant or market issues.
Confirms:Lease revenue from UHS facilities goes up compared to Q1 2026.
Disproves:Lease revenue from UHS facilities goes down compared to Q1 2026.
Why it matters: Completion of this medical plaza is key for future revenue growth. Delays could hurt income.
Confirms:Miller Medical Plaza will be done on time by Q4 2026.
Disproves:Construction delays push completion past Q4 2026.
Why it matters: If revenue growth picks up, it could signal a positive shift in the sector's maturity phase.
Confirms:Q1 earnings report shows revenue growth above 5% year over year.
Disproves:Q1 earnings report shows revenue growth below 0% year over year.
Why it matters: Increased borrowing capacity supports growth plans. A failure to utilize it could signal caution.
Confirms one read:The company shares new projects that will use the extra borrowing.
Confirms the other:No new projects or investments were shared, despite having more borrowing.
Why it matters: Changes to the credit agreement could affect how the Trust uses its money.
Confirms one read:A press release shows better terms in the credit agreement.
Confirms the other:A press release reveals stricter terms or increased costs in the credit agreement.
Results of Operations and Financial Condition. On April 27, 2026, the Trust made its first quarter, 2026 earnings release. A copy of the Trust’s press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Entry into a Material Definitive Agreement. On April 21, 2026, Universal Health Realty Income Trust (the “Trust”) entered into a First Amendment (the “First Amendment”) to the Second Amended and Restated Credit Agreement, among the Trust, the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent, Bank of America, N.A., as Syndication Agent, Fifth Third Bank, N.A., JPMorgan Chase Bank, N.A., PNC Bank, National Association, Truist Bank and U.S. Bank National…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in “
Results of Operations and Financial Condition. On February 25, 2026, the Trust made its fourth quarter, 2025 earnings release. A copy of the Trust’s press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.